series-a
Stage
1
Investors
About
PleoPharma, Inc. is a clinical-stage pharmaceutical company developing therapies for central nervous system and substance-abuse disorders, including cannabis-related conditions. Its lead program has successfully completed Phase 2 clinical trials.
Explore PleoPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.